Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences
BRISBANE, Calif.--(BUSINESS WIRE)--Mar 2, 2020--
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will present at the following investor conferences:
- Cowen 40 th Annual Health Care Conference
Presentation Date: Wednesday, March 4 th at 10:00 a.m. Eastern Time
Location: Boston, MA
- Barclays Global Healthcare Conference
Presentation Date: Wednesday, March 11 th at 8:30 a.m. Eastern Time
Location: Miami, FL
Presentations will be webcast live and may be accessed via a link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. The presentation will also be available on the Sangamo website after the event.
About Sangamo Therapeutics
Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, ex vivo gene-edited cell therapy, and in vivo genome editing and genome regulation. For more information about Sangamo, visit www.sangamo.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20200302005338/en/
CONTACT: Investor Relations – Global
email@example.comMedia Inquiries – Global
KEYWORD: UNITED STATES NORTH AMERICA MASSACHUSETTS CALIFORNIA FLORIDA
INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL GENETICS HEALTH
SOURCE: Sangamo Therapeutics, Inc.
Copyright Business Wire 2020.
PUB: 03/02/2020 08:30 AM/DISC: 03/02/2020 08:30 AM